ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

Clearinghouse Says In Business

January 26, 1979

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

NCI Programs: BSA Approves concept For Grants Program In Statistical Modeling

July 16, 1999

Pressure On Reagan To Appoint Scientists to NCAB Increases with Demand From Powerful Congressman

March 9, 1984